Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-15

Clinical Trial Update: Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP [Phase 3]

View source ↗

Summary

Phase 3 trial comparing decitabine plus dexamethasone versus dexamethasone alone for management of immune thrombocytopenia, status not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Decitabine (Decitabine)

Snippet

Sponsor: Shandong University | Conditions: Purpura, Thrombocytopenic, Idiopathic, Immune Thrombocytopenia | Phase 3 | Status: UNKNOWN